期刊文献+

Influence of CD133^+ expression on patients' survival and resistance of CD133^+ cells to anti-tumor reagents in gastric cancer

Influence of CD133^+ expression on patients' survival and resistance of CD133^+ cells to anti-tumor reagents in gastric cancer
下载PDF
导出
摘要 Objective:To investigate the influence of CD133+expression on patients'survival and resistance of CD133+cells to anti-tumor agents in gastric cancer(GC).Methods:Influence of CD133 expression on prognosis was analyzed employing samples from patients with GC.GC cell lines were utilized to separate CD133+and CD133-subpopulations by immunomagnetic separation and to analyze the biological features of two subpopulations in vitro and in vivo,especially in resistant to anti-tumor reagents and its apoptotic mechanism.Results:The lower CD133+group showed a significantly better survival compared with the higher CD133+group.The highest content of CD133+subpopulations for KATO-III cells had stronger proliferative ability than CD133-subpopulations.A single CD133+cell was capable of generating new cell colony and the tumorigenicity rate in nude mice was100%for CD133+clonal spheres or for CD133+cells,but 0%for CD133-cells.Furthermore,the higher expression levels of Oct-4,Sox-2,Musashi-1 and ABCG2 in CD133+clonal spheres were identified compared with CD133+cells or CD133-cells.Under the treatment of anti-tumor reagents,CD133+cells had lower suppression rates compared with CD133-cells while lower level of Bcl-2 and higher level of Bax were found in CD133+cells compared with CD133-cells.Conclusions:The patients with lower CD133+expression had a better survival.Enriched CD133+cells in clonal sphere shared the ability to be self-renewable,proliferative,tumorigenic and resistant to anti-tumor agents as probably regulated by Bcl-2 and Bax. Objective:To investigate the influence of CD133+expression on patients’survival and resistance of CD133+cells to anti-tumor agents in gastric cancer(GC).Methods:Influence of CD133 expression on prognosis was analyzed employing samples from patients with GC.GC cell lines were utilized to separate CD133+and CD133-subpopulations by immunomagnetic separation and to analyze the biological features of two subpopulations in vitro and in vivo,especially in resistant to anti-tumor reagents and its apoptotic mechanism.Results:The lower CD133+group showed a significantly better survival compared with the higher CD133+group.The highest content of CD133+subpopulations for KATO-III cells had stronger proliferative ability than CD133-subpopulations.A single CD133+cell was capable of generating new cell colony and the tumorigenicity rate in nude mice was100%for CD133+clonal spheres or for CD133+cells,but 0%for CD133-cells.Furthermore,the higher expression levels of Oct-4,Sox-2,Musashi-1 and ABCG2 in CD133+clonal spheres were identified compared with CD133+cells or CD133-cells.Under the treatment of anti-tumor reagents,CD133+cells had lower suppression rates compared with CD133-cells while lower level of Bcl-2 and higher level of Bax were found in CD133+cells compared with CD133-cells.Conclusions:The patients with lower CD133+expression had a better survival.Enriched CD133+cells in clonal sphere shared the ability to be self-renewable,proliferative,tumorigenic and resistant to anti-tumor agents as probably regulated by Bcl-2 and Bax.
出处 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2015年第12期996-1004,共9页 亚太热带生物医学杂志(英文版)
基金 Supported by grants of Shanghai Committee of Science and Technology(09411962300) Shanghai Bureau of Health(2010018) National Nature Science Foundation(81101850)
关键词 STOMACH Cancer CD133 Tumor initiating cells Stomach Cancer CD133 Tumor initiating cells
  • 相关文献

参考文献20

  • 1Jacques Ferlay,Isabelle Soerjomataram,Rajesh Dikshit,Sultan Eser,Colin Mathers,Marise Rebelo,Donald Maxwell Parkin,David Forman,Freddie Bray.SJWD14121600000297[J]. Int. J. Cancer . 2015 (5)
  • 2Abdelouahid El-Khattouti,Natale T. Sheehan,Jesus Monico,Heather A. Drummond,Youssef Haikel,Robert T. Brodell,Mosaad Megahed,Mohamed Hassan.CD133 + melanoma subpopulation acquired resistance to caffeic acid phenethyl ester-induced apoptosis is attributed to the elevated expression of ABCB5: Significance for melanoma treatment[J]. Cancer Letters . 2014
  • 3Gulperi Oktem,Ayhan Bilir,Ruchan Uslu,Sevinc Inan,Sirin Demiray,Harika Atmaca,Sule Ayla,Ogun Sercan,Aysegul Uysal.Expression profiling of stem cell signaling alters with spheroid formationin CD133high/CD44high prostate cancer stem cells[J]. Oncology Letters . 2014 (6)
  • 4Youlong Zhu,Jiwei Yu,Shoulian Wang,Ruiqi Lu,Jugang Wu,Bojian Jiang.Overexpression of CD133 enhances chemoresistance to 5-fluorouracil byactivating the PI3K/Akt/p70S6K pathway in gastric cancer cells[J]. Oncology Reports . 2014 (6)
  • 5Suresh Kumar Swaminathan,Emilie Roger,Udaya Toti,Lin Niu,John R. Ohlfest,Jayanth Panyam.CD133-Targeted Paclitaxel Delivery Inhibits Local Tumor Recurrence in a Mouse Model of Breast Cancer[J].Journal of Controlled Release.2013
  • 6Philipp Grosse‐Gehling,Christine A Fargeas,Claudia Dittfeld,Yvette Garbe,Malcolm R Alison,Denis Corbeil,Leoni A Kunz‐Schughart.CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges[J]. J. Pathol . 2012 (3)
  • 7Farbod Shojaei.Anti-angiogenesis therapy in cancer: Current challenges and future perspectives[J]. Cancer Letters . 2012 (2)
  • 8Xiao-Guang Lv,Meng-Yao Ji,Wei-Guo Dong,Xiao-Fei Lei,Meng Liu,Xu-Feng Guo,Jing Wang,Chuo Fang.EBP50 gene transfection promotes 5-fluorouracil-induced apoptosis ingastric cancer cells through Bax- and Bcl-2-triggered mitochondrial pathways[J]. Molecular Medicine Reports . 2012 (5)
  • 9Aristides G.Vaiopoulos,Ioannis D.Kostakis,MichaelKoutsilieris,Athanasios G.Papavassiliou.Colorectal Cancer Stem Cells[J].STEM CELLS.2012(3)
  • 10Douglas Hanahan,Robert A. Weinberg.Hallmarks of Cancer: The Next Generation[J]. Cell . 2011 (5)

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部